Latest Breaking News On - Minimise invasive surgery - Page 1 : comparemela.com

Adlai Nortye Ltd. announced that the first patient was dosed in the Phase II clinical trial known as ARTEMIS . This clinical study evaluates palupiprant , a small molecule prostaglandin E receptor 4 .

Adlai nortyeSimon gollinsMark saundersCancer researchEisai coAdlai nortye ltdEuropean society for medical oncologyUniversity of leedsMinimise invasive surgeryClinical trials unitProf simon gollinsProf markEuropean societyMedical oncology